We are live on
!
Find out more
TAM
Tocqueville Asset Management Portfolio holdings
AUM
$7.56B
1-Year Est. Return
44.87%
This Fund
S&P 500
This Quarter
Est. Return
+10.4%
1 Year Est. Return
+44.87%
3 Year Est. Return
+121.98%
5 Year Est. Return
+153.06%
10 Year Est. Return
+501.33%
AUM
$5.23B
AUM Growth
+$432M
(+9%)
Cap. Flow
-$77.4M
Cap. Flow
% of AUM
-1.48%
Top 10 Holdings %
Top 10 Hldgs %
25.64%
Holding
696
New
43
Increased
170
Reduced
285
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$22.8M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$18.4M |
| 3 |
Elanco Animal Health
ELAN
|
+$14.8M |
| 4 |
Newmont
NEM
|
+$13.1M |
| 5 |
Boston Properties
BXP
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$12.9M |
| 2 |
NVIDIA
NVDA
|
+$9.88M |
| 3 |
Las Vegas Sands
LVS
|
+$9.7M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$9.63M |
| 5 |
Cisco
CSCO
|
+$8.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Consumer Discretionary | 17.32% |
| 3 | Healthcare | 12.32% |
| 4 | Miscellaneous | 11.15% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
iShares Silver Trust
SLV
$33.7B
| $225K | ﹤0.01% |
+10,400
| New | +$236K |
|
|
XLRN
552
DELISTED
Acceleron Pharma
XLRN
| $225K | ﹤0.01% |
+2,000
| New | +$199K |
|
553
Corpay
CPAY
$26.5B
| $224K | ﹤0.01% |
940
-7,340
| -89% | -$1.81M |
|
554
The Mosaic Company
MOS
$7.58B
| $220K | ﹤0.01% |
12,050
-4,500
| -27% | -$73.2K |
|
555
Rio Tinto
RIO
$170B
| $218K | ﹤0.01% |
3,618
-32
| -0.9% | -$1.96K |
|
|
TDF
556
Templeton Dragon Fund
TDF
$272M
| $218K | ﹤0.01% |
9,925
| – | – |
|
557
Blackrock
BLK
$181B
| $217K | ﹤0.01% |
385
-50
| -11% | -$28.5K |
|
558
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
| $215K | ﹤0.01% |
635
-280
| -31% | -$95.6K |
|
559
FMC
FMC
$1.34B
| $214K | ﹤0.01% |
2,020
-2,605
| -56% | -$279K |
|
560
LyondellBasell Industries
LYB
$20.3B
| $214K | ﹤0.01% |
3,039
-14
| -0.5% | -$968 |
|
561
Darling Ingredients
DAR
$9.74B
| $212K | ﹤0.01% |
+5,872
| New | +$180K |
|
562
Conagra Brands
CAG
$7.71B
| $211K | ﹤0.01% |
5,900
-496
| -8% | -$18.2K |
|
563
Ryder
R
$9.51B
| $211K | ﹤0.01% |
+5,000
| New | +$202K |
|
564
Brookfield Infrastructure Partners
BIP
$17.8B
| $207K | ﹤0.01% |
+6,525
| New | +$192K |
|
|
CTRA
565
DELISTED
Coterra Energy
CTRA
| $205K | ﹤0.01% |
+11,800
| New | +$221K |
|
566
The 3D Printing ETF
PRNT
$64.5M
| $205K | ﹤0.01% |
+8,560
| New | +$198K |
|
567
Trade Desk
TTD
$6.28B
| $205K | ﹤0.01% |
3,950
-1,900
| -32% | -$86.8K |
|
568
BioXcel Therapeutics
BTAI
$22.5M
| $204K | ﹤0.01% |
+294
| New | +$221K |
|
569
Truist Financial
TFC
$61.4B
| $203K | ﹤0.01% |
5,326
-138
| -3% | -$5.2K |
|
570
ProShares Short QQQ
PSQ
$596M
| $192K | ﹤0.01% |
+2,320
| New | +$200K |
|
571
Sprott Physical Gold and Silver Trust
CEF
$8.3B
| $187K | ﹤0.01% |
10,200
| – | – |
|
572
Amkor Technology
AMKR
$12.8B
| $178K | ﹤0.01% |
15,894
+5,627
| +55% | +$69.7K |
|
573
DHT Holdings
DHT
$3.14B
| $173K | ﹤0.01% |
+33,586
| New | +$186K |
|
|
NBSE
574
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $154K | ﹤0.01% |
+1,018
| New | +$166K |
|
|
ZUO
575
DELISTED
Zuora, Inc.
ZUO
| $131K | ﹤0.01% |
+12,700
| New | +$147K |
|
Similar funds
RIG
EDRH
HPC
O
CIA
BFM
CCM
CCWA
Tocqueville Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, Tocqueville Asset Management held 696 positions worth $5.23B, up 9% from $4.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Tocqueville Asset Management's Q3 2020 filing shows 43 new, 170 increased, 285 reduced and 48 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 225,520 shares worth $17.2M. The largest sale was Apple, an estimated $12.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Tocqueville Asset Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 225,520 shares worth $17.2M.
- Tocqueville Asset Management added most to Charles Schwab in Q3 2020, an estimated $18.4M increase.
- Tocqueville Asset Management's biggest Q3 2020 reduction was Apple, cutting an estimated $12.9M.
- Tocqueville Asset Management fully exited Las Vegas Sands in Q3 2020, selling an estimated $9.7M.
- Tocqueville Asset Management's ten largest holdings make up 26% of its $5.23B portfolio in Q3 2020.
- Tocqueville Asset Management opened 43 new positions and closed 48 in Q3 2020.
- Tocqueville Asset Management's portfolio value rose 9% quarter-over-quarter to $5.23B.
Based on Tocqueville Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.